How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

10,517 results for

E/M History Criteria

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. E/M History Criteria

E/M History Criteria E/M History Criteria Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 E/M History Criteria E/M History Criteria (...) Aka: E/M History Criteria , E/M Problem Focused History , E/M Expanded Problem Focused History , E/M Detailed History , E/M Comprehensive History II. Approach See History of Present Illness (HPI): 8 Components (Must be asked by provider) Location Severity Timing Modifying factors Quality Duration Context Associated signs and symptoms Past Medical, and Social History (PFSH) - may be obtained by form, scribe, CMA or other staff Past Medical History Social History (ROS): 14 components (may

2018 FP Notebook

2. E/M History Criteria

E/M History Criteria E/M History Criteria Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 E/M History Criteria E/M History Criteria (...) Aka: E/M History Criteria , E/M Problem Focused History , E/M Expanded Problem Focused History , E/M Detailed History , E/M Comprehensive History II. Approach See History of Present Illness (HPI): 8 Components (Must be asked by provider) Location Severity Timing Modifying factors Quality Duration Context Associated signs and symptoms Past Medical, and Social History (PFSH) - may be obtained by form, scribe, CMA or other staff Past Medical History Social History (ROS): 14 components (may

2015 FP Notebook

3. Appropriate Use Criteria: Imaging of the Brain

Appropriate Use Criteria: Imaging of the Brain 8600 West Bryn Mawr Avenue South Tower – Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable © 2017 ©©©© 2019 AIM Specialty Health 2057-0119 CLINICAL APPROPRIATENESS GUIDELINES ADVANCED IMAGING Appropriate Use Criteria: Imaging of the Brain EFFECTIVE JANUARY 1, 2019 Proprietary Imaging of the Brain Copyright © 2019. AIM Specialty Health. All Rights Reserved. 2 Table of Contents Description and Application (...) of the Guidelines 4 Administrative Guidelines 5 Ordering of Multiple Studies 5 Simultaneous Ordering of Multiple Studies 5 Repeated Imaging 5 Pre-Test Requirements 6 History 6 Imaging of the Brain 7 General Information/Overview 7 Scope 7 Technology Considerations 7 Definitions 8 Clinical Indications 9 Congenital and Developmental Conditions 9 Ataxia, congenital or hereditary 9 Developmental delay (Pediatric only) 9 Congenital cerebral anomalies 10 Infection 10 Infection 10 Inflammatory Conditions 11 Multiple

2019 AIM Specialty Health

4. Appropriate Use Criteria: Imaging of the Abdomen and Pelvis

Appropriate Use Criteria: Imaging of the Abdomen and Pelvis 8600 West Bryn Mawr Avenue South Tower – Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable © 2017 ©©©© 2019 AIM Specialty Health® 2057-0119 CLINICAL APPROPRIATENESS GUIDELINES ADVANCED IMAGING Appropriate Use Criteria: Imaging of the Abdomen and Pelvis EFFECTIVE JANUARY 1, 2019 Proprietary Imaging of the Abdomen and Pelvis Copyright © 2019. AIM Specialty Health. All Rights Reserved. 2 Table of Contents (...) Description and Application of the Guidelines 5 Administrative Guidelines 6 Ordering of Multiple Studies 6 Simultaneous Ordering of Multiple Studies 6 Repeated Imaging 6 Pre-Test Requirements 7 History 7 Imaging of the Abdomen and Pelvis 8 General Information/Overview 8 Scope 8 Technology Considerations 8 Definitions 9 Clinical Indications 11 General Abdominal and Pelvic Indications 11 Congenital and developmental conditions 11 Infectious and inflammatory conditions – not otherwise referenced 11 Trauma 12

2019 AIM Specialty Health

5. Chronic Lung Allograft Dysfunction: Definition, Diagnostic Criteria and Approaches to Treatment. A Consensus Report from the Pulmonary Council of the ISHLT

, please review your options for gaining access at the bottom of the page. Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT x Geert M. Verleden Affiliations Lung Transplant Unit, University Hospital Gasthuisberg, Leuven, Belgium Correspondence Reprint requests: Geert M. Verleden, MD, PhD, Lung Transplantation Unit, University Hospital Gasthuisberg, 49 Herestraat, B-3000 Leuven, Belgium. Telephone (...) Chronic Lung Allograft Dysfunction: Definition, Diagnostic Criteria and Approaches to Treatment. A Consensus Report from the Pulmonary Council of the ISHLT Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT - The Journal of Heart and Lung Transplantation Email/Username: Password: Remember me Search Terms Search within Search Volume 38, Issue 5, Pages 493–503 To read this article in full

2019 International Society for Heart and Lung Transplantation

6. Appropriate Use Criteria: Positron Emission Testing, Other PET Applications, including Oncologic Tumor Imaging

PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole- body scan results. Clin Nucl Med. 2013;38(5):326-331. 38. Ozkan E, Soydal C, Araz M, Aras G, Ibis E. The additive clinical value of 18F-FDG PET/CT in defining the recurrence of disease in patients with differentiated thyroid cancer who have isolated increased antithyroglobulin antibody levels. Clin Nucl Med. 2012;37 (...) Appropriate Use Criteria: Positron Emission Testing, Other PET Applications, including Oncologic Tumor Imaging Clinical Appropriateness Guidelines: Advanced Imaging Appropriate Use Criteria: Positron Emission Testing, Other PET Applications, including Oncologic Tumor Imaging Effective Date: March 12, 2018 Proprietary Date of Origin: 03/30/2005 Last revised: 09/07/2017 Last reviewed: 09/07/2017 Copyright © 2018. AIM Specialty Health. All Rights Reserved 8600 W Bryn Mawr Avenue South Tower

2018 AIM Specialty Health

7. Appropriate Use Criteria: Imaging of the Spine

- evaluation; OR ? Mid-back pain not meeting the above criteria but associated with “red flag” symptoms such as unexplained weight loss, history of malignant disease, fever, drug abuse, or tuberculosis, abnormal labs suggestive of malignancy such as abnormal serum or urine electrophoresis, elevated prostate specific antigen (PSA) Post-operative or post-procedure evaluation Preoperative or pre-procedure evaluation Note: This indication is for pre-operative evaluation of conditions not specifically (...) therapy; AND ? After trial of conservative therapy as listed above, patient fails to show substantial improvement on clinical re- evaluation; OR ? Mid-back pain not meeting the above criteria but associated with “red flag” symptoms such as unexplained weight loss, history of malignant disease, fever, drug abuse, or tuberculosis, abnormal labs suggestive of malignancy such as abnormal serum or urine electrophoresis, elevated prostate specific antigen (PSA) Post-operative or post-procedure evaluation

2018 AIM Specialty Health

8. Appropriate Use Criteria: Imaging of the Head & Neck

/intracranial infection ? Oral contraceptive ? Pregnancy ? Prior episodes of venous sinus thrombosis ? Trauma Management (including perioperative evaluation) of established venous thrombosis References 1. Agid R, Shelef I, Scott JN, Farb RI. Imaging of the intracranial venous system. Neurologist. 2008;14(1):12-22. 2. Agostoni E, Aliprandi A, Longoni M. Cerebral venous thrombosis. Expert Rev Neurother. 2009;9(4):553-564. 3. Albanese A, Asmus F, Bhatia KP, et al. EFNS guidelines on diagnosis and treatment (...) in the Familial Intracranial Aneurysm study: frequency and predictors of lesion detection. J Neurosurg. 2008 Jun;108(6):1132-8. 17. Caranci F, Briganti F, Cirillo L, Leonardi M, Muto M. Epidemiology and genetics of intracranial aneurysms. Eur J Neurol. 2013;82(10):1598-1605. 18. Cardoso TA, Coan AC, Kobayashi E, Guerreiro CA, Li LM, Cendes F. Hippocampal abnormalities and seizure recurrence after antiepileptic drug withdrawal. Neurology. 2006 Jul 11;67(1):134-136. 19. Christiaans MH, Kelder JC, Arnoldus EPJ

2018 AIM Specialty Health

9. Appropriate Use Criteria: Imaging of the Chest

diseases. Radiographics. 2005;25(1):157-173. 77. Tunick PA, Krinsky GA, Lee VS, Kronzon I. Diagnostic imaging of thoracic aortic atherosclerosis. AJR Am J Roentgenol. 2000;174(4):1119-1125. 78. Tüzün E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist. 2007;13(5):261-271. 79. Uresandi F, Monreal M, Garcia-Bragado F, et al. National Consensus on the Diagnosis, Risk Stratification and Treatment of Patients with Pulmonary Embolism. Spanish Society (...) Appropriate Use Criteria: Imaging of the Chest Clinical Appropriateness Guidelines: Advanced Imaging Appropriate Use Criteria: Imaging of the Chest Effective Date: March 12, 2018 Proprietary Date of Origin: 03/30/2005 Last revised: 09/07/2017 Last reviewed: 09/07/2017 Copyright © 2018. AIM Specialty Health. All Rights Reserved 8600 W Bryn Mawr Avenue South Tower - Suite 800 Chicago, IL 60631 P . 773.864.4600 www.aimspecialtyhealth.comTable of Contents | Copyright © 2018. AIM Specialty Health

2018 AIM Specialty Health

10. Appropriate Use Criteria: Imaging of the Abdomen & Pelvis

Committee. J Am Coll Radiol. 2010;7(10):754-773. 11. Brancatelli G, Federle MP, Grazioli L, et al. Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology. 2001;219(1):61-68. 12. Caturelli E, Pompili M, Bartolucci F, Siena DA, Sperandeo M, Andriulli A, Bisceglia M. Hemangioma-like lesions in chronic liver disease: diagnostic evaluation in patients. Radiology. 2001 Aug;220(2):337-342. 13. Chou R, Cuevas C, Fu R, et al. Imaging Techniques for the Diagnosis (...) . 2013;19(1):3-26. 36. Mandeville JA, Gnessin E, Lingeman JE. Imaging evaluation in the patient with renal stone disease. Semin Nephrol. 2011 May;31(3):254-258. 37. Marrero JA, Ahn J, Rajender Reddy K. American College of Gastroenterology clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol. 2014;109(9):1328-1347. 38. Matsuki M, Kani H, Tatsugami F, et al. Preoperative assessment of vascular anatomy around the stomach by 3D imaging using MDCT before laparoscopy

2018 AIM Specialty Health

11. Required hospital capacity in 2025 and criteria for rationalisation of complex cancer surgery, radiotherapy and maternity services

, Grau C, Jeurissen P, Kruse FM, Lefèvre M, Lievens Y, Mistiaen P, Vaandering A, Van Eycken E, van Ginneken E. Required hospital capacity in 2025 and criteria for rationalisation of complex cancer surgery, radiotherapy and maternity services. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). 2017. KCE Reports 289. D/2017/10.273/45. This document is available on the website of the Belgian Health Care Knowledge Centre. KCE Report 289 Required hospital capacity (...) distribution of the M-beds in the hospital sites in Belgium, December 2014 384 Figure 103 – Proportion of M-beds among the total number of licensed beds in Belgium (2014) 388 Figure 104 – Comparison of the number of justified and licensed M-beds for Belgium and the three regions per bed type, 2002-2015 389 Figure 105 – Selection criteria (number of stays) 390 Figure 106 – MDC 14 Pregnancy, Childbirth and Puerperium 392 Figure 107 – Number of deliveries in Belgium, 2008-2014 393 Figure 108 – Number

2017 Belgian Health Care Knowledge Centre

12. Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease

A. Guyton, MD, FACC Mark A. Hlatky, MD, FACC Harold L. Lazar, MD, FACC Vera H. Rigolin, MD, FACC Geoffrey A. Rose, MD, FACC, FASE Richard J. Shemin, MD, FACC Jacqueline E. Tamis-Holland, MD, FACC Carl L. Tommaso, MD, FACC, FSCAI L. Samuel Wann, MD, MACC John B. Wong, MD Appropriate Use Criteria Task Force John U. Doherty, MD, FACC, Co-Chair Gregory J. Dehmer, MD, MACC, Co-Chair Steven R. Bailey, MD, FACC, FSCAI, FAHA Nicole M. Bhave, MD, FACC Alan S. Brown, MD, FACC Stacie L. Daugherty, MD, FACC Milind (...) Manesh R. Patel , John H. Calhoon , Gregory J. Dehmer , James Aaron Grantham , Thomas M. Maddox , David J. Maron and Peter K. Smith This article has a correction. Please see: Author + information vol. 69 no. 17 2212-2241 DOI: Published By: Print ISSN: Online ISSN: History: Published online April 24, 2017. Article Versions You are viewing the most recent version of this article. Copyright & Usage: 2017 American College of Cardiology Foundation Author Information Manesh R. Patel , MD, FACC, FAHA, FSCAI

2017 Society for Cardiovascular Angiography and Interventions

13. 2017 SCAI Appropriate Use Criteria for Peripheral Arterial Interventions

2017 SCAI Appropriate Use Criteria for Peripheral Arterial Interventions SCAI appropriate use criteria for peripheral arterial interventions: An update - Klein - 2017 - Catheterization and Cardiovascular Interventions - Wiley Online Library Search within Search term Search term The full text of this article hosted at iucr.org is unavailable due to technical difficulties. Peripheral Vascular Disease (E‐only Article) Free Access SCAI appropriate use criteria for peripheral arterial interventions (...) , Kansas City, KS Columbia University Medical Center/NY Presbyterian Hospital, New York, NY Beth Israel Deaconess Medical Center, Boston, MA Cleveland Clinic, Cleveland, OH Corresponding Author E-mail address: Ochsner Medical Center, New Orleans, LA Correspondence Christopher J. White, MD, MSCAI, 1514 Jefferson Highway, New Orleans, LA 70121. Email: Piedmont Heart Institute, Atlanta, GA Newton‐Wellesley Hospital, Newton, MA Greenville Health System, Greenville, SC The Warren Alpert Medical School

2017 Society for Cardiovascular Angiography and Interventions

14. Multi-criteria decision analysis for the appraisal of medical needs: a pilot study

: ? the conditions for and level of reimbursement, ? the cohort of patients eligible for ETR (i.e. inclusion- and exclusion criteria) and ? the budget needed for covering the product. Cohort decisions are defined by law e as decisions restricted in time and based on available economic and medical data. The budget is defined yearly. The agent who submits a request for a cohort decision is responsible for the execution of the programme, the designation of a responsible physician for handling the requests (...) a cohort decision exists for that patients’ indication and whether the patient satisfies the eligibility criteria. Patients who are included in the ETR programme have to give their informed consent. e Art. 25quater/1, §1 of the Wet betreffende de verplichte verzekering voor geneeskundige verzorging en uitkeringen, gecoördineerd op 14 juli 1994 KCE Report 272 Multi-criteria decision analysis for the appraisal of medical needs 11 Key points ? The unmet medical needs procedures foresees in the possibility

2016 Belgian Health Care Knowledge Centre

15. Management of menopausal symptoms in women with a history of breast cancer

are listed below. Vasomotor Symptoms Sleep disturbance Vulvovaginal symptoms and sexual function Non-pharmacological therapies Cognitive behavioural therapy Yoga Acupuncture Hypnotherapy Exercise Cognitive behavioural therapy Relaxation therapy Hypnotherapy Acupuncture Vitamin E Non-hormonal vaginal gels Cognitive behavioural therapy Non-hormonal vaginal moisturisers Vaginal lubricants Management of menopausal symptoms in women with a history of breast cancer page 7 of 181Black cohosh Homeopathy Magnetic (...) in women with a history of breast cancer. C ES54 12 Purpose-designed hypnotherapy can be considered for the management of sleep disturbance in women with a history of breast cancer. C ES22 13 Acupuncture can be considered for the management of sleep disturbance in women with a history of breast cancer. C ES23 14 Vitamin E is not recommended for the management of sleep disturbance in women with a history of breast cancer due to evidence that it is not effective. C ES24 Management of menopausal symptoms

2017 Cancer Australia

16. History, politics and vulnerability: explaining excess mortality

History, politics and vulnerability: explaining excess mortality History, politics and vulnerability: explaining excess mortality in Scotland and Glasgow David Walsh, Gerry McCartney, Chik Collins, Martin Taulbut, G David Batty May 2016 A report by the Glasgow Centre for Population Health, NHS Health Scotland, the University of the West of Scotland and University College London 1 David Walsh is a Public Health Programme Manager at the Glasgow Centre for Population Health; Gerry McCartney (...) Glasgow & Clyde/Glasgow Centre for Population Health • Professor Mike Danson, Professor of Enterprise Policy, Heriot-Watt University • Professor Sir Tom Devine, Emeritus Chair of Scottish History and Palaeography, The University of Edinburgh • Professor Danny Dorling, Professor of Geography, University of Oxford • Dr Flora Douglas, Lecturer in Public Health, University of Aberdeen • Ruth Dundas, Senior Investigator Scientist, MRC/CSO Social & Public Health Sciences Unit, University of Glasgow • Jackie

2016 Glasgow Centre for Population Health

17. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Published in the March 2015 issue of Genetics in M

as the strength of the criteria for a benign (left side) or pathogenic (right side) assertion. Evidence code descriptions can be found in and . BS, benign strong; BP, benign supporting; FH, family history; LOF, loss of function; MAF, minor allele frequency; path., pathogenic; PM, pathogenic moderate; PP, pathogenic supporting; PS, pathogenic strong; PVS, pathogenic very strong. The following is provided to more thoroughly explain certain concepts noted in the criteria for variant classification (...) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Published in the March 2015 issue of Genetics in M Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology | Genetics in Medicine Thank you

Full Text available with Trip Pro

2015 Association for Molecular Pathology

18. Revision of the Jones Criteria for the Diagnosis of Acute Rheumatic Fever in the Era of Doppler Echocardiography

and the rationale for their application to help identify changes in valvar status associated with ARF are discussed below. These changes are listed in and and are analogous to valvular abnormalities also described in RHD in the recent World Heart Federation statement on that condition. Table 3. Doppler Findings in Rheumatic Valvulitis Pathological mitral regurgitation (all 4 criteria met) Seen in at least 2 views Jet length ≥2 cm in at least 1 view Peak velocity >3 m/s Pansystolic jet in at least 1 envelope (...) Pathological aortic regurgitation (all 4 criteria met) Seen in at least 2 views Jet length ≥1 cm in at least 1 view Peak velocity >3 m/s Pan diastolic jet in at least 1 envelope Loading conditions should be accounted for at time of echocardiography/Doppler assessment (see the section Differential Diagnosis of ARF for a full discussion). This table reflects an amalgam of the findings from the references listed in and other guideline statements , and also resembles findings described in rheumatic heart

Full Text available with Trip Pro

2015 American Heart Association

19. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke

on Epidemiology and Prevention Bart M. Demaerschalk , Dawn O. Kleindorfer , Opeolu M. Adeoye , Andrew M. Demchuk , Jennifer E. Fugate , James C. Grotta , Alexander A. Khalessi , Elad I. Levy , Yuko Y. Palesch , Shyam Prabhakaran , Gustavo Saposnik , Jeffrey L. Saver , and Eric E. Smith and on behalf of the American Heart Association Stroke Council and Council on Epidemiology and Prevention Originally published 22 Dec 2015 Stroke. 2015;47:581–641 You are viewing the most recent version of this article (...) (0.7) 4 (0.2) Major surgery in preceding 14 d 11 (0.6) 1 (0.1) Previous intracranial hemorrhage 9 (0.5) 1 (0.1) Aneurysm 7 (0.4) 0 (0) Platelet count <100 000 5 (0.3) 2 (0.1) MI in previous 3 mo 2 (0.1) 0 (0) Gastrointestinal/urinary tract hemorrhage in previous 21 d 1 (0.1) 0 (0) Serum glucose <50 mg/dL 1 (0.1) 0 (0) Brain tumor 1 (0.1) 0 (0) AVM 0 0 Active bleeding/acute trauma 0 0 Noncompressive arterial puncture in previous 7 d 0 0 ECASS III exclusion criteria Age >80 y … 15 (0.8) History

Full Text available with Trip Pro

2015 American Heart Association

20. Medical eligibility criteria for contraceptive use

Medical eligibility criteria for contraceptive use Department of Reproductive Health and Research World Health Organization Avenue Appia 20, CH-1211 Geneva 27 Switzerland Fax: +41 22 791 4171 E-mail: reproductivehealth@who.int www.who.int/reproductivehealth For more information, please contact: COCs Barrier methods IUDs Fertility awareness-based methods Lactational Coitus interruptus Copper IUD for amenorrhoea Patch Female surgical sterilization Intrauterine devices CICs emergency contraception (...) study): incidence ratio 9.2 (95% CI 6.5–13) CI: confidence interval; OR: odds ratio. a Based on 5 studies, 4 of which reported incidence by week and 1 of which reported the proportion of VTE events by week. b Based on 6 studies.Medical eligibility criteria for contraceptive use - Part I | 37 References 1. Jackson E, Glasier A. Return of ovulation and menses in postpartum nonlactating women: a systematic review. Obstet Gynecol. 2011;117(3):657–62. 2. Petersen JF, Bergholt T, Nielsen AK, Paidas MJ

2015 World Health Organisation Guidelines

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>